Therapeutic strategies for pediatric non-alcoholic fatty liver disease: a challenge for health care providers
- PMID: 17552019
- PMCID: PMC4146832
- DOI: 10.3748/wjg.v13.i18.2639
Therapeutic strategies for pediatric non-alcoholic fatty liver disease: a challenge for health care providers
Abstract
Non-alcoholic steato-hepatitis (NASH) is related to insulin resistance and, thus, frequently occurs as part of the metabolic changes that accompany obesity, diabetes and hyperlipidemia. In childhood, the overwhelming boost of obesity and its co-morbidities have lead to the extraordinarily increased prevalence of NASH. Establishing effective therapeutic strategies to treat the disease represents the challenge for hepatologists and gastroenterologists in the next decade. Therapeutic approaches have aimed at treating associated conditions (obesity, insulin resistance, hyperlipemia, etc) or reducing liver oxidative damage (vitamin E).
Similar articles
-
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.World J Gastroenterol. 2016 Sep 28;22(36):8078-93. doi: 10.3748/wjg.v22.i36.8078. World J Gastroenterol. 2016. PMID: 27688650 Free PMC article. Review.
-
Non-alcoholic steatohepatitis in children.Pediatr Transplant. 2004 Dec;8(6):613-8. doi: 10.1111/j.1399-3046.2004.00241.x. Pediatr Transplant. 2004. PMID: 15598336 Review.
-
Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:68-76. doi: 10.1111/jgh.12212. J Gastroenterol Hepatol. 2013. PMID: 23855299 Review.
-
Nonalcoholic fatty liver disease: a challenge for pediatricians.Int J Obes (Lond). 2010 Oct;34(10):1451-67. doi: 10.1038/ijo.2010.185. Epub 2010 Sep 14. Int J Obes (Lond). 2010. PMID: 20838401 Review.
-
[Non-alcoholic fatty liver disease--new view].Pol Merkur Lekarski. 2008 Jun;24(144):568-71. Pol Merkur Lekarski. 2008. PMID: 18702346 Review. Polish.
Cited by
-
Predictors of non-alcoholic fatty liver disease in obese and overweight Egyptian children: single center study.Saudi J Gastroenterol. 2011 Jan-Feb;17(1):40-6. doi: 10.4103/1319-3767.74476. Saudi J Gastroenterol. 2011. PMID: 21196652 Free PMC article.
-
Alanine aminotransferase elevation in obese infants and children: a marker of early onset non alcoholic Fatty liver disease.Hepat Mon. 2014 Apr 7;14(4):e14112. doi: 10.5812/hepatmon.14112. eCollection 2014 Apr. Hepat Mon. 2014. PMID: 24748893 Free PMC article.
-
Circulating adipokines in children with nonalcoholic fatty liver disease: possible noninvasive diagnostic markers.Ann Gastroenterol. 2017;30(4):457-463. doi: 10.20524/aog.2017.0148. Epub 2017 Apr 25. Ann Gastroenterol. 2017. PMID: 28655985 Free PMC article.
References
-
- Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr. 2006;43:413–427. - PubMed
-
- Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr. 2000;136:727–733. - PubMed
-
- Park HS, Han JH, Choi KM, Kim SM. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr. 2005;82:1046–1051. - PubMed
-
- Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, Kusano Y. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci. 1995;40:2002–2009. - PubMed
-
- Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics. 2005;115:e561–e565. - PubMed